Adjuvant Immunotherapy for Liver Transplant Recipients with Hepatocellular Carcinoma Using Donor Liver Derived Natural Killer Cells

被引：0
|
作者：
Ohira, M. [1 ]
Hotta, R. [1 ]
Imaoka, Y. [1 ]
Sato, K. [1 ]
Tanimine, N. [1 ]
Tahara, H. [1 ]
Ide, K. [1 ]
Kobayashi, T. [1 ]
Tanaka, Y. [1 ]
Tzakis, A. [2 ]
Nishida, S. [2 ]
Ohdan, H. [1 ]
机构：
[1] Hiroshima Univ, Hiroshima, Japan
[2] Univ Miami, Miami, FL USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2020年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
251
引用
收藏
页码：492 / 492
页数：1
相关论文
共 50 条
  • [21] A novel concept of adoptive immunotherapy using interleukin-2-stimulated liver natural killer cells for treatment of liver transplantation with hepatocellular carcinoma
    Ohira, M.
    Nishida, S.
    Tryphonopoulos, P.
    Tekin, A.
    Selvaggi, G.
    Moon, J.
    Levi, D.
    Feun, L. G.
    Ruiz, P.
    Ricordi, C.
    Ishiyama, K.
    Ohdan, H.
    Tzakis, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [22] Living Donor Liver Transplant for Hepatocellular Carcinoma
    Subramanian, Vijay
    Chapman, William
    ANNALS OF SURGICAL ONCOLOGY, 2019, 26 (06) : 1594 - 1595
  • [23] Living Donor Liver Transplant for Hepatocellular Carcinoma
    Vijay Subramanian
    William Chapman
    Annals of Surgical Oncology, 2019, 26 : 1594 - 1595
  • [24] Use of Adjuvant Sorafenib in Liver Transplant Recipients with High-Risk Hepatocellular Carcinoma
    Shetty, Kirti
    Dash, Chiranjeev
    Laurin, Jacqueline
    JOURNAL OF TRANSPLANTATION, 2014, 2014
  • [25] Harnessing immunotherapy for liver recipients with hepatocellular carcinoma: a review from a transplant oncology perspective
    Ho, Cheng-Maw
    Chen, Hui-Ling
    Hu, Rey-Heng
    Lee, Po-Huang
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2019, 11
  • [26] Liver natural killer cell inoculum for liver transplantation with hepatocellular carcinoma
    Nishida, Seigo
    Levi, David M.
    Tzakis, Andreas G.
    CURRENT OPINION IN ORGAN TRANSPLANTATION, 2013, 18 (06) : 690 - 694
  • [27] Strategies of Immunosuppression for Liver Transplant Recipients With Hepatocellular Carcinoma
    Castroagudin, J. F.
    Molina-Perez, E.
    Ferreiro-Iglesias, R.
    Varo-Perez, E.
    TRANSPLANTATION PROCEEDINGS, 2011, 43 (03) : 711 - 713
  • [28] Adoptive Immunotherapy With Deceased Donor Derived-Liver Natural Killer (NK) Cells Is Well Tolerated and Has the Potential to Become a Powerful Therapeutic Tool for Preventing Recurrence of Hepatocellular Carcinoma After Liver Transplantation
    Hotta, R.
    Nishida, S.
    Muraoka, I.
    Ohira, M.
    Ohdan, H.
    Vianna, R.
    TRANSPLANTATION, 2014, 98 : 167 - 167
  • [29] Liver Resection as Bridging Downstaging Treatment for Hepatocellular Carcinoma in Liver Transplant Recipients
    Giacomoni, Alessandro
    Slim, Abdallah
    Di Sandro, Stefano
    Lauterio, Andrea
    Mihaylov, Plamen
    Pirotta, Vincenzo
    De Carlis, Luciano
    AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 : 445 - 445
  • [30] Targeted immune cell therapy for hepatocellular carcinoma using expanded liver mononuclear cell-derived natural killer cells
    Hu, Xin
    Shui, Yifang
    Shimizu, Seiichi
    Sakamoto, Seisuke
    Kasahara, Mureo
    Okada, Seiji
    Guo, Wen-Zhi
    Fujino, Masayuki
    Li, Xiao-Kang
    NEOPLASIA, 2024, 58
12345